|
Dexrazoxane placebo Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- Beth Israel Deaconess Medical Center1
Indications
- Heart Disease1
- Cardiotoxicity1
- Diffuse Large B-cell Lymphoma(DLBCL)1
- Lymphoma1
- Cancer1
Boston, Massachusetts1 trial
The CARDIOPROTECT Trial
Beth Israel Deaconess Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.